
==== Front
Surg Case Rep
Surg Case Rep
Surgical Case Reports
2198-7793
Springer Berlin Heidelberg Berlin/Heidelberg

39249641
2012
10.1186/s40792-024-02012-7
Case Report
Laparoscopic sleeve gastrectomy as a bridge to colorectal cancer surgery for obese patients: a case report
Minagawa Yume 12
http://orcid.org/0000-0003-0989-8577
Amiki Manabu amiki0727@gmail.com

1
Yuki Keisuke 1
Watanabe Kazuharu 1
Mochizuki Ichitaro 1
Ishiyama Yasuhiro 12
Hara Yoshiaki 1
Narita Kazuhiro 1
Hirano Yasumitsu 2
1 Department of Surgery, Kawasaki Saiwai Hospital, 31-27 Omiya-Cho, Saiwai-Ku, Kawasaki-Shi, Kanagawa 212-0014 Japan
2 https://ror.org/04zb31v77 grid.410802.f 0000 0001 2216 2631 Saitama Medical University International Medical Center, Hidaka City, Saitama Japan
9 9 2024
9 9 2024
12 2024
10 21112 7 2024
29 8 2024
© The Author(s) 2024
2024
https://creativecommons.org/licenses/by/4.0/ Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Background

Severe obesity greatly influences the difficulty of colorectal cancer surgery and has been reported to prolong operative time, increase the rate of laparotomy, and elevate increase postoperative complications. We investigated the efficacy of laparoscopic sleeve gastrectomy (LSG) for preoperative weight loss to ensure safe colorectal cancer surgery.

Case presentation

A 51 year-old female with a body mass index of 43.5 kg/m2 was referred to our hospital due to a positive fecal occult blood test. She was diagnosed as having a laterally spreading tumor of the cecum by colonoscopy. Endoscopic submucosal dissection was attempted but proved difficult due to the size of the lesion and its proximity to the appendiceal orifice. We planned bariatric surgery prior to colorectal surgery, and she underwent LSG without any complications. Seven months after the LSG, she had lost 30.7 kg, and her final preoperative body mass index was 27.8 kg/m2. Single-incision laparoscopic ileocecal resection was then performed safely. The pathological diagnosis was adenocarcinoma in adenoma of the cecum, TisN0M0.

Conclusion

LSG was effective in reducing visceral fat and making it possible to perform safe surgery for colorectal cancer in a severely obese patient.

Keywords

Bridge bariatric surgery
Colorectal cancer
Sleeve gastrectomy
issue-copyright-statement© Japan Surgical Society 2024
==== Body
pmcBackground

The number of obese patients is increasing in Japan [1], and opportunities to treat these patients with colorectal cancer are also rising. In recent years, most colorectal cancer surgeries have been performed laparoscopically. A randomized controlled trial (JCOG 0404 study) conducted in Japan reported that the long-term prognosis of laparoscopic colorectal cancer surgery for obese patients with a body mass index (BMI) of 25 kg/m2 or more was worse than that of open surgery [2]. In obese patients, the intra-abdominal working space is narrower, making it difficult to obtain a good field of view and to protect tissues due to their fragility. Additionally, visceral fat affects the visualization of anatomic structures.

Weight loss is necessary for obese patients to safely undergo oncologic surgery, but significant weight loss is difficult to achieve with therapies such as diet and exercise. Metabolic and bariatric surgery is the most effective treatment for severe obesity and its associated medical problems [3]. Laparoscopic sleeve gastrectomy (LSG) has been the most commonly performed metabolic and bariatric surgery since 2014, with acceptable operative times, intraoperative blood loss, and perioperative complication rates [4]. Here, we report a case of LSG performed as a bridge procedure for early-stage colorectal cancer surgery.

Case presentation

The patient was a 51 year-old female with hypertension managed with medication. She visited the gastroenterology department because of a positive fecal occult blood test and was diagnosed via endoscopy as having a laterally spreading tumor (25 mm × 25 mm) of the cecum. The polyp was pedunculated with smooth borders and no ulceration or hemorrhage. Blood investigations revealed a normal hemoglobin (13.4 g/dL). Tumor marker values were CEA 1.4 U/mL and CA19-9 2.0 ng/mL. The endoscopist judged this lesion to be amenable to endoscopic resection as an adenoma with a well-defined glandular ductal structure through assessment with magnifying endoscopy. Endoscopic submucosal dissection was attempted but was difficult due to the size of the lesion and its proximity to the appendiceal orifice. She was then referred to our department for surgical resection planning. Endoscopic findings showed a laterally spreading tumor of the cecum (Fig. 1), and biopsy results indicated a tubular adenoma. Computed tomography scans showed no metastasis. The preoperative diagnosis was adenoma or early adenocarcinoma of the cecum.Fig. 1 Endoscopic findings. Endoscopic image shows a laterally spreading tumor of the cecum

Her height was 154.9 cm, body weight was 104.5 kg, and BMI was 43.5 kg/m2. Given the technical difficulties anticipated due to severe obesity, we planned LSG seven months after the first consultation prior to resection of the primary tumor.

Although we recommended that she undergo early LSG, we had to wait seven months for the LSG due to her family circumstances. We judged that this period of time might be allowable because adenoma or early-stage cancer was assumed based on various findings. During the waiting period, she was on a restricted diet with nutritional guidance.

LSG was performed using a standardized surgical technique with a 37.5-Fr bougie without any complications. The operation time was 100 min, and blood loss was minimal. She was discharged three days after surgery. Endoscopy showed no change in tumor morphology or size at five months after the LSG. The trends in her change in body weight and visceral fat area at the level of the umbilicus are shown in Fig. 2. Her body weight decreased from 97.0 kg (BMI 40.4 kg/m2) to 66.0 kg (BMI 27.8 kg/m2) over six months. Visceral fat decreased by 45.4%, and the percent of excess weight loss was 82.3%. Her hypertension went into remission, and she no longer required medication.Fig. 2 The patient’s trend in body weight and visceral fat area. The table shows the trend in body weight and visceral fat area, and the images show the change in visceral fat area at the level of the umbilicus

Surgical procedure

We then performed ileocecal resection and lymph node dissection via single-incision laparoscopic surgery (Fig. 3). The operation was performed via a 3-cm longitudinal incision at the umbilicus. A 12-mm camera port and two 5-mm ports were inserted through an E・Z Access device (Hakko, Nagano, Japan). Mesenteric mobilization was started on the anterior surface of the duodenum (Fig. 4). The ileocolic artery and vein were exposed and dissected (D2 lymph node dissection), and the colon was dissected for tumor resection. We then performed a functional end-to-end anastomosis. The operation time was 108 min, and blood loss was minimal. The number of lymph nodes harvested was 29. She was discharged seven days after surgery without any complications. The pathological diagnosis was adenocarcinoma in adenoma, TisN0M0, pStage 0.Fig. 3 Intraoperative photographs show ileocecal resection via single-incision laparoscopic surgery and the surgical wound postoperatively

Fig. 4 Intraoperative photographs show findings after easy dissection (left panel) and the resected specimen (right panel)

Discussion

Severe obesity significantly affects the difficulty of colorectal cancer surgery [2]. The increased difficulty of surgical procedures in obese patients has been attributed to the narrow free space in the abdominal cavity, difficulty in excluding the small intestine from the field of view, the weight of heavy organs, tissue fragility, and difficulty in understanding the anatomy of the blood vessels and nerves.

Previous studies have reported that the degree of visceral fat is related to surgery time and the incidence of surgical complications such as surgical site infection and anastomotic failure [5], and fewer lymph nodes are harvested [6]. Visceral fat area is a more useful parameter than BMI in predicting surgical outcomes after laparoscopic colorectal surgery [5].

After LSG, visceral fat decreases in correlation with the amount of weight loss achieved [7]. The decrease in visceral fat after LSG allows for more free space in the abdominal cavity and also facilitates expansion of the visual field, making for safer cancer surgery.

The 2022 ASMBS and IFSO guidelines describe bariatric surgery as a bridge procedure for joint replacement, abdominal wall hernia repair, and organ transplantation [8]. However, these guidelines do not describe bridge surgery for oncologic surgery, and there are a few papers describing such cases.

Gianos et al. reported LSG as a bridge surgery in one case of small bowel carcinoma, two cases of renal tumors, and one case of prostate cancer [9]. Iwata et al. performed LSG followed by thoracoscopic radical surgery for lung cancer detected preoperatively before LSG [10], and Chemaly et al. performed LSG as a bridge procedure in five patients with cancer and severe obesity [11]. Performance of bariatric surgery prior to malignant tumor resection is controversial in terms of disease progression. There is no literature on how long an interval is acceptable for colorectal cancer. Therefore, there are no definitive inclusion criteria for performing bariatric surgery prior to primary tumor resection.

The preoperative clinical diagnosis in this case was tubular adenoma or very early-stage cancer, and resection was indicated. LSG was performed prior to oncologic surgery to reduce the difficulty of the procedure and the possibility of perioperative complications due to obesity. There are currently no recommended criteria for the timing of surgery after LSG. In the 10 patients in the three papers presented here, most underwent oncologic surgery between three and six months after LSG [9–11]. Their mean BMI at baseline was 47.2 kg/m2 and that before tumor surgery was 37.3 kg/m2 [9–11]. In our patient, LSG also resulted in good weight loss. Because weight loss after LSG is generally rapid up to six months later, we recommend oncologic surgery six months after LSG for early-stage cancer if time permits [12]. Regarding the application of LSG to advanced cancer, it may be considered for cases in which it is possible to wait three to six months due to neoadjuvant therapy before resection of the primary tumor. Safe and reliable D3 dissection may be expected with visceral fat reduction.

Obesity is known to be associated with a high risk of developing many cancers, and the risk of developing colorectal cancer is reported to correlate with obesity status and visceral fat mass [13]. In Japan, the incidence of colorectal cancer is increasing, and it is now the leading cause of cancer-related death in women and the second leading cause of death in men [14]. Therefore, the number of cases requiring bridge surgery may increase, and it will be necessary to discuss the effectiveness of surgery after LSG and the timing of surgery based on the accumulation of more cases in the future. It has also been reported that bariatric surgery reduces the risk of cancer, including colorectal cancer, and LSG as a bridge surgery may be effective in reducing the risk of new colorectal cancers in the future [15].

Conclusion

LSG was effective in achieving preoperative weight loss before colorectal surgery in a severely obese patient by reducing visceral fat and enabling a safe surgery.

Abbreviations

BMI Body mass index

LSG Laparoscopic sleeve gastrectomy

Acknowledgements

The authors thank Dr. Tina Tajima for editing a draft of this manuscript.

Author contributions

All authors were involved in the management of the patient and conception of the manuscript. YM drafted the case report. All authors have read and approved the final version of the manuscript and agree to be accountable for all aspects of the work.

Funding

Not applicable.

Availability of data and materials

The data that support the findings of this study are openly available from the corresponding author upon reasonable request.

Declarations

Ethics approval and consent to participate

This study received institutional review board approval (approval no.: R5-18), and it conforms to the provisions of the Declaration of Helsinki. The patient gave informed consent, and patient anonymity was preserved.

Consent for publication

Written informed consent was obtained from the patient for publication of this case report and any accompanying images.

Competing of interests

The authors have no conflicts of interest to declare.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
==== Refs
References

1. The National Health and Nutrition Survey (NHNS) Japan 2019. Ministry of health, labour and welfare. https://www.nibiohn.go.jp/eiken/kenkounippon21/download_files/eiyouchousa/2019.pdf. Accessed 6 Jun 2024.
2. Kitano S Inomata M Mizusawa J Katayama H Watanabe M Yamamoto S Survival outcomes following laparoscopic versus open D3 dissection for stage II or III colon cancer (JCOG0404): a phase 3 randomised controlled trial Lancet Gastroenterol Hepatol 2017 2 4 261 268 10.1016/S2468-1253(16)30207-2 28404155
Kitano S, Inomata M, Mizusawa J, Katayama H, Watanabe M, Yamamoto S, et al. Survival outcomes following laparoscopic versus open D3 dissection for stage II or III colon cancer (JCOG0404): a phase 3 randomised controlled trial. Lancet Gastroenterol Hepatol. 2017;2(4):261–8.28404155 10.1016/S2468-1253(16)30207-2
3. Sjöström L Review of the key results from the Swedish Obese Subjects (SOS) trial–a prospective controlled intervention study of bariatric surgery J Int Med 2013 273 3 219 234 10.1111/joim.12012
Sjöström L. Review of the key results from the Swedish Obese Subjects (SOS) trial–a prospective controlled intervention study of bariatric surgery. J Int Med. 2013;273(3):219–34.10.1111/joim.12012
4. Angrisani L Santonicola A Iovino P Ramos A Shikora S Kow L Bariatric Surgery Survey 2018: similarities and disparities among the 5 IFSO chapters Obes Surg 2021 31 1937 1948 10.1007/s11695-020-05207-7 33432483
Angrisani L, Santonicola A, Iovino P, Ramos A, Shikora S, Kow L. Bariatric Surgery Survey 2018: similarities and disparities among the 5 IFSO chapters. Obes Surg. 2021;31:1937–48.33432483 10.1007/s11695-020-05207-7
5. Watanabe J Tatsumi K Ota M Suwa Y Suzuki S Watanabe A The impact of visceral obesity on surgical outcomes of laparoscopic surgery for colon cancer Int J Colorectal Dis 2014 29 343 351 10.1007/s00384-013-1803-9 24297037
Watanabe J, Tatsumi K, Ota M, Suwa Y, Suzuki S, Watanabe A, et al. The impact of visceral obesity on surgical outcomes of laparoscopic surgery for colon cancer. Int J Colorectal Dis. 2014;29:343–51.24297037 10.1007/s00384-013-1803-9
6. Yang T Wei M He Y Deng X Wang Z Impact of visceral obesity on outcomes of laparoscopic colorectal surgery: a meta-analysis ANZ J Surg 2015 85 7–8 507 513 10.1111/ans.13132 25902904
Yang T, Wei M, He Y, Deng X, Wang Z. Impact of visceral obesity on outcomes of laparoscopic colorectal surgery: a meta-analysis. ANZ J Surg. 2015;85(7–8):507–13.25902904 10.1111/ans.13132
7. Sun J Lv H Li M Zhao L Liu Y Zeng N How much abdominal fat do obese patients lose short term after laparoscopic sleeve gastrectomy? a quantitative study evaluated with MRI Quant Imag Med Surg 2021 11 11 4569 4582 10.21037/qims-20-1380
Sun J, Lv H, Li M, Zhao L, Liu Y, Zeng N, et al. How much abdominal fat do obese patients lose short term after laparoscopic sleeve gastrectomy? a quantitative study evaluated with MRI. Quant Imag Med Surg. 2021;11(11):4569–82.10.21037/qims-20-1380
8. Eisenberg D Shikora SA Aarts E Aminian A Angrisani L Cohen RV 2022 American Society of Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) indications for metabolic and bariatric surgery Obes Surg 2023 33 1 15 16 10.1007/s11695-022-06369-2 36445365
Eisenberg D, Shikora SA, Aarts E, Aminian A, Angrisani L, Cohen RV, et al. 2022 American Society of Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) indications for metabolic and bariatric surgery. Obes Surg. 2023;33(1):15–6.36445365 10.1007/s11695-022-06369-2
9. Gianos M Abdemur A Szomstein S Rosenthal R Laparoscopic sleeve gastrectomy as a step approach for morbidly obese patients with early-stage malignancies requiring rapid weight loss for a final curative procedure Obes Surg 2013 23 1370 1374 10.1007/s11695-013-0933-z 23564466
Gianos M, Abdemur A, Szomstein S, Rosenthal R. Laparoscopic sleeve gastrectomy as a step approach for morbidly obese patients with early-stage malignancies requiring rapid weight loss for a final curative procedure. Obes Surg. 2013;23:1370–4.23564466 10.1007/s11695-013-0933-z
10. Iwata S Hagiwara A Harima Y Thoracoscopic radical surgery for a morbidly obese patient with early lung cancer after laparoscopic sleeve gastrectomy: a case report Surg Case Rep 2020 6 189 10.1186/s40792-020-00950-6 32737617
Iwata S, Hagiwara A, Harima Y. Thoracoscopic radical surgery for a morbidly obese patient with early lung cancer after laparoscopic sleeve gastrectomy: a case report. Surg Case Rep. 2020;6:189.32737617 10.1186/s40792-020-00950-6
11. Chemaly R Ibrahim Z Lainas P Ghaida MA Kassir NE Al-Hajj G Laparoscopic sleeve gastrectomy as a first step procedure for oncologic purposes: an indication beyond the updated guidelines Obes Surg 2024 34 6 2026 2032 10.1007/s11695-024-07257-7 38714594
Chemaly R, Ibrahim Z, Lainas P, Ghaida MA, Kassir NE, Al-Hajj G, et al. Laparoscopic sleeve gastrectomy as a first step procedure for oncologic purposes: an indication beyond the updated guidelines. Obes Surg. 2024;34(6):2026–32.38714594 10.1007/s11695-024-07257-7
12. Boza C Salinas J Salgado N Pérez G Raddatz A Funke R Laparoscopic sleeve gastrectomy as a stand-alone procedure for morbid obesity: report of 1000 cases and 3 year follow-up Obes Surg 2012 22 866 871 10.1007/s11695-012-0591-6 22438219
Boza C, Salinas J, Salgado N, Pérez G, Raddatz A, Funke R, et al. Laparoscopic sleeve gastrectomy as a stand-alone procedure for morbid obesity: report of 1000 cases and 3 year follow-up. Obes Surg. 2012;22:866–71.22438219 10.1007/s11695-012-0591-6
13. Larsson SC Wolk A Obesity and colon and rectal cancer risk: a meta-analysis of prospective studies Am J Clin Nutr 2007 86 3 556 565 10.1093/ajcn/86.3.556 17823417
Larsson SC, Wolk A. Obesity and colon and rectal cancer risk: a meta-analysis of prospective studies. Am J Clin Nutr. 2007;86(3):556–65.17823417 10.1093/ajcn/86.3.556
14. Cancer Statistics. Cancer information service, National Cancer Center, Japan (Vital Statistics of Japan, Ministry of Health, Labour and Welfare).
15. Janik MR Clapp B Sroczyński P Ghanem O The effect of bariatric surgery on reducing the risk of colorectal cancer: a meta-analysis of 3,233,044 patients Surg Obes Relat Dis 2023 19 4 328 334 10.1016/j.soard.2022.10.003 36446716
Janik MR, Clapp B, Sroczyński P, Ghanem O. The effect of bariatric surgery on reducing the risk of colorectal cancer: a meta-analysis of 3,233,044 patients. Surg Obes Relat Dis. 2023;19(4):328–34.36446716 10.1016/j.soard.2022.10.003
